Lopez L L, Yu X, Cui D, Davis M R
ThermoQuest Finnigan, San Jose, CA 95134, USA.
Rapid Commun Mass Spectrom. 1998;12(22):1756-60. doi: 10.1002/(SICI)1097-0231(19981130)12:22<1756::AID-RCM381>3.0.CO;2-C.
A rapid and systematic strategy for the identification of drug metabolites in biological matrices based on liquid chromatography-tandem mass spectrometry (LC/MS/MS) techniques was utilized for the identification of drug metabolites of the HIV protease inhibitor Indinavir. This strategy integrates intelligent realtime mass spectrometry with HPLC detection and a predictive strategy for detecting metabolites arising from common biotransformations, to rapidly elucidate structures of drug metabolites. Structures of metabolites generated from in vitro incubation mixtures of Indinavir were characterized from a single chromatographic analysis using the automated LC/MS/MS methodology, thus reducing data acquisition time and improving efficiency.